Clorazepate dipotassium and Topamax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clorazepate dipotassium (clorazepate dipotassium) and Topamax (topiramate). Common drug interactions include convulsion among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Clorazepate dipotassium and Topamax. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Clorazepate dipotassium?

Clorazepate dipotassium has active ingredients of clorazepate dipotassium. It is often used in stress and anxiety. eHealthMe is studying from 2,708 Clorazepate dipotassium users. Check the latest studies of Clorazepate dipotassium.

What is Topamax?

Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 58,954 Topamax users. Check the latest studies of Topamax.



On Jul, 08, 2026

46 people who take Clorazepate dipotassium and Topamax together, and have interactions are studied.

Clorazepate dipotassium and Topamax drug interactions.

What are the common drug interactions of Clorazepate Dipotassium and Topamax, by gender? *:

female:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Anticonvulsant drug level decreased
  3. Rash
  4. Adverse drug reaction
  5. Diarrhoea
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Headache (pain in head)
  8. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  9. Abdominal pain
  10. Atelectasis (partial or complete collapse of the lung)

male:

  1. Vomiting
  2. Diarrhoea
  3. Aggression
  4. Agitation (state of anxiety or nervous excitement)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Constipation
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Diabetic coma
  9. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  10. Disease complication

What are the common drug interactions of Clorazepate Dipotassium and Topamax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Vomiting
  2. Diarrhoea
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  5. Hypersomnia (excessive daytime sleepiness (eds))
  6. Pyrexia (fever)
  7. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)

10-19:

  1. Anticonvulsant drug level decreased
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Blood carbon dioxide decreased
  4. Blood chloride increased
  5. Death
  6. Hypokalaemia (low potassium)
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

20-29:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Cough
  4. Diarrhoea
  5. Disease complication
  6. Dry skin
  7. Hyperglycaemia (high blood sugar)
  8. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  9. Pancreatitis (inflammation of pancreas)

30-39:

  1. Abdominal distension
  2. Aggression
  3. Agitation (state of anxiety or nervous excitement)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Completed suicide (act of taking one's own life)
  6. Constipation
  7. Headache (pain in head)
  8. Pancreatitis (inflammation of pancreas)
  9. Rash
  10. Respiratory tract infection

40-49:

  1. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  2. Type 2 diabetes mellitus
  3. Depressed level of consciousness
  4. Asthma
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Diabetes mellitus inadequate control
  8. Diabetic coma
  9. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  10. Hepatitis (inflammation of the liver)

50-59:

n/a

60+:

  1. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  2. Calciphylaxis (is a syndrome with vascular calcium accumulation)
  3. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  4. Mitral valve incompetence (inefficient heart valve)
  5. Renal failure (kidney dysfunction)
  6. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  7. Cardiac failure congestive
  8. Cerebral atrophy (decrement in size of brain)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 13.04%
  2. Depression: 6 people, 13.04%
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 10.87%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 8.70%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.70%
  6. Constipation: 4 people, 8.70%
  7. Asthma: 4 people, 8.70%
  8. Wax Blockage: 3 people, 6.52%
  9. Teething (process by which an infant's first teeth grows): 3 people, 6.52%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Clorazepate dipotassium and Topamax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clorazepate dipotassium and Topamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clorazepate dipotassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Topamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clorazepate dipotassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Topamax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clorazepate dipotassium and topiramate (the active ingredients of Clorazepate dipotassium and Topamax, respectively), and Clorazepate dipotassium and Topamax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: